nebularine has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klenow, H; Marcussen, M; Overgaard-Hansen, K | 1 |
| Fu, NW | 1 |
2 other study(ies) available for nebularine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Net uptake of orthophosphate in Ehrlich ascites tumor cells in the presence of purine riboside may be rate limiting for the expansion of the pool of ribonucleotides.
Topics: Animals; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Phosphates; Purine Nucleosides; Ribonucleosides; Ribonucleotides; Sodium; Tumor Cells, Cultured | 1994 |
[Protection of cells by nucleoside transport inhibitor combined with nebularine and the therapeutic effect on transplantable mouse tumors].
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Benzyl Compounds; Carcinoma, Ehrlich Tumor; Cell Division; Cell Survival; Deoxyadenosines; Dilazep; Female; Leukemia, Experimental; Mice; Mice, Inbred Strains; Purine Nucleosides; Ribonucleosides | 1985 |